NCT05329155Completed
Early Administration of Heparin At FMC for PPCI of STEMI Patients
Effectiveness and Safety of Early Administration of Heparin At First Medical Contact for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention: a Multicenter, Prospective, Randomized, Controlled Study
Source: ClinicalTrials.gov · Last updated 27 Mar 2025
Brief summary (registry, in English)
Heparin is the first choice of anticoagulation drug for primary PCI of STEMI patients. However, the priority of use of hepairn in first medical contact or in Cathlab has not yet studied. Previous study revealed early use of antithrombotic drugs could improve patient's survival. Here we supposed that use of heparin at first medical contact could increase the TIMI flow 3 grade ratio in STEMI patients and improve patient's survival and/or reduce MACE rather than in Cathlab.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 1145 (actual)
- First submitted
- 29 Mar 2022
- Start date
- 20 Jul 2022
- Primary completion date
- 20 Aug 2023
- Lead sponsor
- Renmin Hospital of Wuhan University
- Diseases
- Coronary artery disease
- NCT number
- NCT05329155
What you commit to
- Study type: Interventional
- Participants enrolled: 1145
- From 20 Jul 2022 to the primary completion date, 20 Aug 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Active bleeding; Life expectancy less than 1 year; History of heparin-induced thrombocytopenia; Mechanical complication of MI (VSR, acute MR); History of CABG; On Coagulation drugs; CPR before randomization; Pregnant or lactating woman.
Who the study is looking for
- STEMI patient; Symptom onset in 12 hours; Intended to perform PPCI
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Renmin Hospital of Wuhan University Coordinator of this site? Confirm its status | Wuhan | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.